These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 224379

  • 1. [From the hormonology of mastopathies to breast cancer prevention].
    Mauvais-Jarvis P.
    Nouv Presse Med; 1979 May 19; 8(22):1817-9. PubMed ID: 224379
    [No Abstract] [Full Text] [Related]

  • 2. [Hormonal physiology of the breast].
    de Lignières B.
    Rev Prat; 1975 Sep 01; 25(37):2861-6. PubMed ID: 170660
    [No Abstract] [Full Text] [Related]

  • 3. [Problems concerning the formation, preservation and regression of the corpus luteum in rats].
    Alloiteau JJ, Mayer G.
    Arch Anat Microsc Morphol Exp; 1967 Sep 01; 56(3):189-257. PubMed ID: 5615164
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hormonal function of the ovarian corpus luteum during benign mammary diseases].
    Mauvais-Jarvis P, Tamborini A, Sterkers N, Ohlgiesser G, Mowszowicz I.
    J Gynecol Obstet Biol Reprod (Paris); 1975 Sep 01; 4(7):965-70. PubMed ID: 1219052
    [Abstract] [Full Text] [Related]

  • 8. [New data on the mechanisms of the luteinizing action of estrogens and progesterone during the estrus cycle of rats].
    Roos J, Roos M, Aron C.
    C R Seances Soc Biol Fil; 1973 Sep 01; 167(12):1968-71. PubMed ID: 4807710
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Biologic bases of the treatment of diffuse benign breast diseases].
    Van Bogaert LJ.
    J Gynecol Obstet Biol Reprod (Paris); 1976 Jun 01; 5(4):567-75. PubMed ID: 783246
    [Abstract] [Full Text] [Related]

  • 11. Benign breast disease I: hormonal investigation.
    Sitruk-Ware R, Sterkers N, Mauvais-Jarvis P.
    Obstet Gynecol; 1979 Apr 01; 53(4):457-60. PubMed ID: 571588
    [Abstract] [Full Text] [Related]

  • 12. Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.
    Sherman BM, Wallace RB, Korenman SG.
    Breast Cancer Res Treat; 1981 Apr 01; 1(4):287-96. PubMed ID: 6816318
    [No Abstract] [Full Text] [Related]

  • 13. [Breast histophysiology and pathology. I].
    Van Bogaert LJ.
    Rev Fr Gynecol Obstet; 1984 Mar 01; 79(3):157-227. PubMed ID: 6531593
    [No Abstract] [Full Text] [Related]

  • 14. [Hormones and breast cancer. Current views].
    Molinatti GM, Limone P.
    Minerva Med; 1982 Apr 21; 73(17):1047-53. PubMed ID: 6281687
    [No Abstract] [Full Text] [Related]

  • 15. Mammary developmental fate and breast cancer risk.
    Medina D.
    Endocr Relat Cancer; 2005 Sep 21; 12(3):483-95. PubMed ID: 16172188
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Current studies of the influence of hormones in the pathogenesis and prognosis of breast cancer].
    Deslypere JP.
    Verh K Acad Geneeskd Belg; 1987 Sep 21; 49(4):310-44. PubMed ID: 3318205
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Steroid hormone receptors in breast cancer].
    Moyano C, Puga J, Calaf G, Rojas C.
    Rev Chil Obstet Ginecol; 1984 Sep 21; 49(1):15-25. PubMed ID: 6099905
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.